about
Prevalence, determinants, and inappropriateness of calcium supplementation among men and women in a Spanish Mediterranean area: cross-sectional data from the ESOSVAL cohort.Impact of a multifaceted intervention to improve the clinical management of osteoporosis. The ESOSVAL-F study.Use of osteoporosis medications after hospitalization for hip fracture: a cross-national studyOveruse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain.Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol.Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study.[Variability in the recommendations for the clinical management of osteoporosis].Efficacy of osteoporosis therapies in a network meta-analysis with indirect comparisons: many concerns for new tools of evidence synthesis?Impact on the population of different bone mineral density testing criteria and appropriateness of densitometries in the ESOSVAL cohort, Spain.Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.Prevalence of osteoporosis in the ESOSVAL cohort: reply to the comment by Pedrera-Zamorano et alVertebral fracture risk factors in postmenopausal women over 50 in Valencia, Spain. A population-based cross-sectional studyReal-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysisQuality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world studyPrevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of observational studies.Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical OutcomesImproving the accuracy of medication adherence measures using linked prescription and dispensation data: findings from the ESOSVAL cohort of patients treated with osteoporosis drugsData resource profile: the Valencia health system integrated database (VID)
P50
Q30623972-52B8187E-7B45-4495-A3AB-72DAFA78A868Q33724697-1F536091-C07A-4C60-8569-71960C265BBCQ35554696-7B73913E-5B0A-4BAF-8295-EC973469694EQ35759160-DCC931AA-57A0-417B-AE2E-48B80F16A891Q36179688-0F15EBEA-3854-470A-97C7-F3D0AD865889Q41717921-643C1342-740F-42B3-A6EA-4190D1408287Q43524861-3470E5B1-B0C1-49F7-9C21-C151DA9D538EQ45713330-54150D03-6E7F-4BB0-9FB6-1C4FC31B0DBDQ50481515-065E4662-1C4E-44C8-AA6B-C77C425CECE6Q52563793-F5DCF639-6DDA-45DF-8F70-4E44460EE756Q57753019-1858DCD9-202A-40D0-B53A-41F176C57B80Q57753093-FC4AE4B6-B701-4DF4-BBB5-75BBFE64106DQ60946403-D26E1915-DE62-4493-913E-70AD1F7DE829Q64238280-6C4CF1D4-6D6D-4D47-8302-3E2D00BB538AQ64982856-2ED20DA8-AC1B-404E-9E9A-C6E947AB35DAQ91435691-759E0825-DDEF-4C41-9CE1-BEB15D85A636Q92696317-CC7BC3F5-6A6B-4160-8C28-B5D2C71A3140Q92907964-83D19113-524C-4163-AF33-79A6B383A12C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Isabel Hurtado
@en
Isabel Hurtado
@nl
type
label
Isabel Hurtado
@en
Isabel Hurtado
@nl
prefLabel
Isabel Hurtado
@en
Isabel Hurtado
@nl
P31
P496
0000-0002-8475-8112